|
|
|
Volumn 271, Issue 3, 1994, Pages 1383-1390
|
|
Development of cross-tolerance between Δ9-tetrahydrocannabinol, CP 55,940 and WIN 55,212
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE;
4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL;
CANNABINOID RECEPTOR;
DRONABINOL;
DRUG VEHICLE;
ANIMAL EXPERIMENT;
ANTINOCICEPTION;
ARTICLE;
CATALEPSY;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG CROSS TOLERANCE;
DRUG EFFECT;
DRUG MECHANISM;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
HYPOTHERMIA;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
MOTOR ACTIVITY;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
RECTUM TEMPERATURE;
SUBCUTANEOUS DRUG ADMINISTRATION;
TAIL FLICK TEST;
ANALGESICS;
ANIMAL;
BODY TEMPERATURE;
CYCLOHEXANOLS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG TOLERANCE;
MALE;
MICE;
MICE, INBRED ICR;
MORPHOLINES;
MOTOR ACTIVITY;
NAPHTHALENES;
SUPPORT, NON-U.S. GOV'T;
SUPPORT, U.S. GOV'T, P.H.S.;
TETRAHYDROCANNABINOL;
|
|
EID: 0028170932
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (119)
|
|
References (0)
|
